Return to search

Immuneering nets $62m Series B

Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing.

Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing. Cormorant Asset Management led the round.

Source: Press Release